State Of Tennessee, Treasury Department Cara Therapeutics, Inc. Transaction History

State Of Tennessee, Treasury Department

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$4.89 - $12.27 $4,498 - $11,288	-920 Reduced 5.66%	15,338 $75,000
Q3 2022 Jan 26, 2023	BUY	$8.24 - $12.56 $6,130 - $9,344	744 Added 4.8%	16,258 $152,000
Q1 2022 May 11, 2022	SELL	$9.94 - $12.65 $122,947 - $156,467	-12,369 Reduced 44.36%	15,514 $188,000
Q4 2021 Feb 15, 2022	BUY	$11.99 - $18.14 $96,075 - $145,355	8,013 Added 40.33%	27,883 $339,000
Q3 2021 Nov 12, 2021	SELL	$11.55 - $16.06 $147,967 - $205,744	-12,811 Reduced 39.2%	19,870 $308,000
Q2 2021 Aug 11, 2021	BUY	$12.38 - $29.19 $404,590 - $953,958	32,681 New	32,681 $467,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

Stay updated on State Of Tennessee, Treasury Department with notifications on news.